HUTCHMED (China) Ltd
HCM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001648257
No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.
Other share classesHMDCF
Q3 2025 vs. Q2 2025
How the institutions holding HUTCHMED (China) Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 63 | 58 | −5 |
| Shares | 6.09M | 5.78M | −307.9K (−5.1%) |
| Value | $91.7M | $90.9M | −$736.2K (−0.8%) |
New holders (3)
Institutions that held HUTCHMED (China) Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GTS Securities LLC | 82,132 | $1.29M | 0.05% |
| Rockefeller Capital Management L.P. | 1,135 | $17.9K | 0.00% |
| Bell Investment Advisors, Inc | 129 | $2.03K | 0.00% |
Sold out (8)
Institutions that held HUTCHMED (China) Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 289,135 | $4.35M |
| Catalyst Funds Management Pty Ltd | 109,845 | $1.65M |
| Two Sigma Investments, LP | 27,641 | $416.0K |
| Alberta Investment Management Corp | 23,900 | $359.7K |
| D. E. Shaw & Co., Inc. | 11,373 | $171.2K |
| Raymond James Financial Inc | 614 | $9.24K |
| Northwestern Mutual Wealth Management Co | 94 | $1.42K |
| The PNC Financial Services Group, Inc. | 51 | $768 |